BN Business News
Add your company to Business Communicator →

International trade · 23/04/2018

Valeant Pharmaceuticals Files Complaint with U.S. International Trade Commission Over Clidinium Bromide Products

Valeant Pharmaceuticals has filed a complaint with the U.S. International Trade Commission alleging that Valeant Pharmaceuticals North America LLC and Valeant Pharmaceuticals International Inc. have been unfairly competing with certain clidinium bromide products imported into the US, threatening the US industry.

Source: Federal Register — International Trade CommissionOpen original release →